New Drug Application News and Research

RSS
NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Sunovion receives Complete Response Letter from FDA for dasotraline NDA

Researchers publish new paper on developing vaccine candidates for Helminthic parasites

Researchers publish new paper on developing vaccine candidates for Helminthic parasites

FDA grants approval for first generic version of epinephrine auto-injector

FDA grants approval for first generic version of epinephrine auto-injector

CFDA accepts Ascletis’ NDA for first all-oral HCV treatment

CFDA accepts Ascletis’ NDA for first all-oral HCV treatment

Pivotal study of dasotraline in adults with binge eating disorder meets primary endpoint

Pivotal study of dasotraline in adults with binge eating disorder meets primary endpoint

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix resubmits NDA for DEXTENZA

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Celgene announces regulatory information about investigational compound for relapsing multiple sclerosis

Celgene announces regulatory information about investigational compound for relapsing multiple sclerosis

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

FDA to expedite orphan drug processing queues

FDA to expedite orphan drug processing queues

FDA takes important steps to increase patient access to prescription drugs

FDA takes important steps to increase patient access to prescription drugs